Markets look set to open with a cautious tone as stock futures have been largely flat, reflecting investor hesitation amid a mixed earnings backdrop and geopolitical jitters.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tech-sector weakness led the decline in global equities, while the prolonged U.S. government shutdown continues to cloud data visibility, limiting clarity for the Federal Reserve and markets alike.
Inflation is creeping back into the spotlight as markets digest analysis suggesting the U.S. economy may now be operating in a “higher-inflation regime,” which could complicate the Fed’s expected path of rate cuts.
On the commodities front, gold and silver have pulled back from recent highs, underscoring how quickly sentiment can shift when yields and risk-assets wobble.
In pre-market trading, S&P 500 futures rose 0.07%, Nasdaq futures fell 0.14% and Dow futures are flat.
Check out this morning’s top movers from around Wall Street, compiled by The Fly.
HIGHER –
- Avadel Pharmaceuticals (AVDL) up 4% after Alkermes (ALKS) agreed to acquire Avadel for up to $20.00 per share in cash
- DraftKings (DKNG) up 3% after announcing the acquisition of Railbird Technologies and confirming the upcoming launch of DraftKings Predictions
UP AFTER EARNINGS –
- Amphenol (APH) up 7%
- Vertiv (VRT) up 7%
- GE Vernova (GEV) up 4%
- Thermo Fisher (TMO) up 2%
- Boston Scientific (BSX) up 2%
- Hilton (HLT) up 2%
- AT&T (T) up 1%
DOWN AFTER EARNINGS –
- UniFirst (UNF) down 7%
- Teledyne (TDY) down 2%
- Moody’s (MCO) down 1%
- CME Group (CME) down 1%
- Netflix (NFLX) down 7%
- Texas Instruments (TXN) down 7%
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVDL:
- Wells Fargo says Avadel settlemnet adds $5 to Jazz Pharmaceuticals DCF
- Alkermes to acquire Avadel Pharmaceuticals for up to $20.00 per share in cash
- Avadel Pharmaceuticals Settles Lawsuits with Jazz Pharmaceuticals
- Avadel announces global settlement of all litigation with Jazz Pharmaceuticals
- 3 Must-See Stocks with Strong-Buy Ratings and a Perfect 10 Score